SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-027382
Filing Date
2016-11-03
Accepted
2016-11-03 16:25:00
Documents
3
Period of Report
2016-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ceru-8k_20161103.htm 8-K 34240
2 EX-99.1 ceru-ex991_37.htm EX-99.1 35789
3 GRAPHIC g201611031631599359635.jpg GRAPHIC 42424
  Complete submission text file 0001564590-16-027382.txt   129719
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 161971961
SIC: 2834 Pharmaceutical Preparations